Development of a fluorimetric detection method for cinnabarinic acid using ortho-tolyl hydrazine as the derivatization reagent

Biomedical Chromatography

Volumn 24, Issue 3, 2010, Pages 231-234

  Iizuka, Hideaki ^a   Obata, Kensaku ^a   Yajima, Takehiko ^a   Ichiba, Hideaki ^a   Fukushima, Takeshi ^a  

^a TOHO UNIVERSITY   (Japan)

Author keywords

Cinnabarinic acid; Fluorescence; HPLC; o tolyl hydrazine

Indexed keywords

AMINO ACIDS; CELL DEATH; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SIGNAL TO NOISE RATIO;

CARBONYL GROUPS; CINNABARINIC ACID; DERIVATIZATION REAGENT; DETECTION METHODS; EXCITATION WAVELENGTH; FLUORIMETRIC DETECTION; HPLC; O-TOLYL HYDRAZINE; THYMOCYTES; TRYPTOPHAN METABOLITE;

HYDRAZINE;

HYDRAZINE DERIVATIVE; ORTHO TOLYL HYDRAZINE; UNCLASSIFIED DRUG;

ARTICLE; DERIVATIZATION; EXCITATION; FLUOROMETRY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SIGNAL NOISE RATIO; THYMOCYTE; TRYPTOPHAN METABOLISM;

EID: 76149099583     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.1281     Document Type: Article

References (18)

1. Christen S, Southwell-Keely PT and Stocker R. Oxidation of 3-hydroxyanthranilic acid to the phenoxazinone cinnabarinic acid by peroxy radicals and by compound I of peroxidases or catalase. Biochemistry 1992a; 31: 8090-8097.
2. Christen S and Stocker R. Simultaneous determination of 3-hydroxyanthranilic and cinnabarinic acid by high-performance liquid chromatography with photometric and electrochemical detection. Analytical Biochemistry 1992b; 200: 273-279.
3. Erhardt S, Blennow K, Nordin C, Skogh E, Lindstrom LH and Engberg G. Kynurenic acid levels are elevated in the cerebrospinal fl uid of patients with schizophrenia. Neuroscience Letters 2001; 313: 96-98.
4. Fukushima T, Mitsuhashi S, Tomiya M, Kawai J, Hashimoto K and Toyo'oka T. Determination of rat brain kynurenic acid by column-switching HPLC with fl uorescence detection. Biomedical Chromatography 2007a; 21: 514-519.
5. Fukushima T, Mitsuhashi S, Tomiya M, Iyo M, Hashimoto K and Toyo'oka T. Determination of kynurenic acid in human serum and its correlation with the concentration of certain amino acids. Clinica Chimica Acta 2007b; 377: 174-178.
6. Hartai Z, Juhasz A, Rimanoczy A, Janaky T, Donko T, Dux L, Penke B, Toth GK, Janka Z and Kalman J. Decreased serum and red blood cell kynurenic acid levels in Alzheimer's disease. Neurochemistry International 2007; 50: 308-313.
7. Hilmas C, Pereira EFR, Alkondon M, Rassoulpour A, Schwarcz R and Albuquerque EX. The brain metabolite kynurenic acid inhibits α7 nicotinic receptor activity and increase non-α7 nicotinic receptor expression: physiopathological implications. Journal of Neuroscience 2001; 21: 7463-7473.
8. Hiramatsu R, Hara T, Akimoto H, Takikawa O, Kawabe T, Isobe K and Nagase F. Cinnabarinic acid generated from 3-hydroxyanthranilic acid strongly induces apoptosis in thymocytes through the generation of reactive oxygen species and the induction of caspase. Journal of Cellular Biochemistry 2008; 103: 42-53.
9. Manthey MK, Pyne SG and Truscott RJ. Mechanism of reaction of 3-hydroxyanthranilic acid with molecular oxygen. Biochimica et Biophysica Acta 1990; 1034: 207-212.
10. Mitsuhashi S, Fukushima T, Kawai J, Tomiya M, Santa T, Imai K and Toyo'oka T. Improved method for the determination of kynurenic acid in rat plasma by column-switching HPLC with post-column fl uorescence detection. Analytica Chimica Acta 2006; 562: 36-43.
11. Mitsuhashi S, Fukushima T, Tomiya M, Santa T, Imai T and Toyo'oka T. Determination of kynurenine levels in rat plasma by high-performance liquid chromatography with pre-column fl uorescence derivatization. Analytica Chimica Acta 2007; 584: 315-321.
12. Myint AM, Kim YK, Verkerk R, Scharpe S, Steinbusch H and Leonard B. Kynurenine pathway in major depression: evidence of impaired neuroprotection. Journal of Affective Disorders 2007; 98: 143-151.
13. Nakashima K, Hidaka Y, Yoshida T, Kuroda N and Akiyama S. Highperformance liquid-chromatographic determination of short-chain aliphatic aldehydes using 4-(N, N-dimethylaminosulphonyl)-7-hydrazino-2,1,3-benzoxadiazole as a fluorescence reagent. Journal of Chromatography B Biomedical Applications 1994; 661: 205-210.
14. Ruddick JP, Evans AK, Nutt DJ, Lightman SL, Rook GAW and Lowry CA. Tryptophan metabolism in the central nervous system: medical implications. Expert Reviews in Molecular Medicine 2006; 8: 1-27.
15. Schwarcz R, Rassoulpour A, Wu HQ, Medoff D, Tamminga CA and Roberts RC. Increased cortical kynurenate content in schizophrenia. Biological Psychiatry 2001; 50: 521-530.
16. Swartz KJ, During MJ, Freese A and Beal MF. Cerebral synthesis and release of kynurenic acid: an endogenous antagonist of excitatory amino acid receptors. Journal of Neuroscience 1990; 10: 2965-2973.
17. Uzu S, Imai K, Nakashima K and Akiyama S. Determination of medroxyprogesterone acetate in serum by HPLC with peroxyoxalate chemiluminescence detection using a fl uorogenic reagent, 4-(N,Ndimethylaminosulphonyl)-7-hydrazino-2,1,3-benzoxadiazole. Journal of Pharmaceutical and Biomedical Analysis 1992; 10: 979-984.
18. Xiao LD, Luo XB, Pi LG, Tang AG and Xiao LD. Simultaneous determination of kynurenine and kynurenic acid concentrations in human serum by HPLC with dual wavelengths fl uorescence detection. Clinica Chimica Acta 2008; 395: 178-180.